The primary objective of this Institute is to provide practical information to non-child and adolescent psychiatrist clinicians or trainees on the use of psychotropic medications in their practices. The presentations include discussions of clinically relevant aspects of pediatric psychopharmacology for ADHD, anxiety disorders, and depression. Recent literature is reviewed and discussions focus on medication selection, initiation, titration, and management. Additionally, management of medications for bipolar disorder, schizophrenia, pervasive developmental disorders, and aggression are addressed. Following the more formal didactics, brief vignettes allow for the application of information from earlier presentations and audience involvement in practical clinical discussions.

Sponsored by the AACAP Pediatric Psychopharmacology Initiative (PPI)